Trial Profile
Immunogenicity of Fluzone HD,A High Dose Influenza Vaccine, In Children With Cancer or HIV.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Influenza virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Pharmacodynamics
- Acronyms FLUHD
- 26 Apr 2016 Results published in the Vaccine
- 14 Jun 2013 Planned End Date changed from 1 May 2013 to 1 Aug 2013 as reported by ClinicalTrials.gov.
- 25 Oct 2012 Planned End Date changed from 1 May 2015 to 1 May 2013 as reported by ClinicalTrials.gov.